Pharmaceutical major Wockhardt has bought out Rhein Biotech GmbH from their 50:50 joint venture, Wockhardt Rhein Biopharm, for an undisclosed sum.
Wockhardt will continue to hold a co-exclusive licence on Rhein
Friday, December 19, 2025 | 01:40 PM ISTहिंदी में पढें
Wockhardt Buys Out Rhein Biotech From Joint Venture
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 27 2002 | 12:00 AM IST
